Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
AstraZeneca
PMV Pharmaceuticals, Inc
Merck Sharp & Dohme LLC
Kivu Bioscience Inc.
Ambrx, Inc.
Alterome Therapeutics, Inc.
Eli Lilly and Company
Eli Lilly and Company
ViroMissile, Inc.
Eli Lilly and Company
AstraZeneca
IntoCell, Inc
Tizona Therapeutics, Inc
AstraZeneca
Clasp Therapeutics, Inc.
Eli Lilly and Company
Angiex, Inc.
NiKang Therapeutics, Inc.
Celcuity Inc
MacroGenics
Nanjing Sanhome Pharmaceutical, Co., Ltd.
AstraZeneca
ALX Oncology Inc.
General Oncology, Inc.
DualityBio Inc.
Artios Pharma Ltd
AstraZeneca
Novartis
Eli Lilly and Company
AstraZeneca
Eli Lilly and Company
Second Life Therapeutics
Onchilles Pharma Inc
Ocellaris Pharma, Inc.
BriaCell Therapeutics Corporation
OncoNano Medicine, Inc.
MOMA Therapeutics
GlaxoSmithKline
Liaoning Medical Diagnosis and Treatment Technology Research and Development Co., Ltd.
Transgene
Pfizer
Novartis
Tempus AI
Massive Bio, Inc.
Pfizer
Hummingbird Bioscience
AstraZeneca
Daiichi Sankyo
Sichuan Baili Pharmaceutical Co., Ltd.